We appreciate your patience. Your content is on the way.
SWOT Analysis
- S
- W
- O
- T
Technical Analysis
Moving Averages
We appreciate your patience. Your content is on the way.
Current Price


- Bullish Moving Averages
- Bearish Moving Averages
Resistance and support
We appreciate your patience. Your content is on the way.
Company Financials
- Profit and loss statement
- Balance sheet
- Quarterly Result
- Ratio
We appreciate your patience. Your content is on the way.
Quick Results Snapshot
We appreciate your patience. Your content is on the way.
Stocks Comparison
Table
Chart
We appreciate your patience. Your content is on the way.
Corporate Action
- Announcement
- Board Meeting
- Dividend
- Split
- Rights
- Events
Insider & Institutional Activity
- Bulk Block Deals
- Insider Trading & SAST
We appreciate your patience. Your content is on the way.
About Beryl Drugs Ltd
Stock PE (TTM)
Promoter Holding
Book Value
ROCE
ROE
Beryl Drugs Limited, based in Indore, was incorporated on August 24, 1993. The Company acquired the running business of M/s Flora and Fauna Remedies Limited on December 15, 1993. The Shares of Company were listed on M.P. Stock Exchange, Bombay Stock Exchange and Ahmedabad Stock Exchange. The Company thereafter has been engaged in the manufacture, sale, and export of branded, generic pharmaceutical formulations in India and internationally. It offers I.V.fluids, and a range of small and large volume injectables. It provides a range of eye/ear drops, veterinary products, and injections. It sells products through sales and distribution network. In addition, it offers research and development, as well as contract manufacturing services. Beryl Drugs Ltd. is based in Indore, India. Beryl emerged into a global network of pharmaceutical manufacturing, research and development, contract manufacturing services and veterinary products. It owns brands like BERI-CEF injection, F-Neuron, Amplicillin INJ, P-Mol, Biprox, B-Flox and many more. The manufacturing facilities of the Company are in compliance with WHO GMP specifications. The Company is in tune with the current manufacturing trends in healthcare industry. The Company is an ISO 9001:2000 certified for quality management, which acknowledges quality as the first and the foremost important aspect into the business of healthcare products.
Beryl Drugs share price as on 17 Jun 2025 is Rs. 19.5. Over the past 6 months, the Beryl Drugs share price has decreased by 48.7% and in the last one year, it has decreased by 45.61%. The 52-week low for Beryl Drugs share price was Rs. 17.35 and 52-week high was Rs. 46.
524606
INE415H01017
Sep
Beryl Drugs Ltd FAQs
You can buy Beryl Drugs Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Beryl Drugs Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of Jun 16, 2025 04:01 PM the closing price of Beryl Drugs Ltd was Rs.19.50.
The latest PE ratio of Beryl Drugs Ltd as of Jun 16, 2025 04:01 PM is 17.26
The latest PB ratio of Beryl Drugs Ltd as of Jun 16, 2025 04:01 PM is 0.96
The 52-week high of Beryl Drugs Ltd share price is Rs. 46.00 while the 52-week low is Rs. 17.35
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Jun 16, 2025 04:01 PM, the market cap of Beryl Drugs Ltd stood at Rs. 9.89 Cr.
Market Outlook
View allWe appreciate your patience. Your content is on the way.